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We have demonstrated by using an in vitro approach that interruption of the OmpK36 porin gene by inser-
tion sequences (ISs) is a common type of mutation that causes loss of porin expression and increased resis-
tance to cefoxitin in Klebsiella pneumoniae. This mechanism also operates in vivo: of 13 porin-deficient cefoxitin-
resistant clinical isolates of K. pneumoniae, 4 presented ISs in their ompK36 gene.
Klebsiella pneumoniae is a major nosocomial pathogen, and
successful chemotherapy is critical for the treatment of infec-
tions caused by this microorganism. Antibiotic-resistant strains
emerge with variable frequency, particularly in the hospital
environment. K. pneumoniae resistance to expanded-spectrum
cephalosporins caused by plasmid-borne extended-spectrum
b-lactamases is a well-documented example and has increased
since the 1980s (11, 14, 17). Additionally, effects in porin ex-
pression contribute to increase the resistance levels provided
by the mechanism described above (12).
We have described porins OmpK36 and OmpK35 (2, 7), the
K. pneumoniae homologues of Escherichia coli porins OmpC
and OmpF, respectively. Clinical isolates of this species express
either OmpK36 or OmpK35 porins or both (6). Recently, we
reported that loss of porins OmpK36 and OmpK35 in ex-
tended-spectrum b-lactamase-producing clinical isolates of
K. pneumoniae caused increased resistance to cefoxitin and
expanded-spectrum cephalosporins (3, 9). The relationship
between porin loss and antimicrobial resistance has also been
demonstrated in other bacterial species (1, 10). However, the
mechanisms leading to porin deficiency and subsequent anti-
microbial resistance are largely unknown. The purpose of the
present study was to identify the mechanisms causing porin
deficiency in clinical isolates of K. pneumoniae. For this pur-
pose, we first used an in vitro approach. We selected cefoxitin-
resistant mutants derived from strain LB4(pSHA2) (9). Strain
LB4 is a porin-deficient, cefoxitin-resistant (MIC, 128 mg/ml)
clinical isolate that reverted to cefoxitin sensitivity (MIC, 4
mg/ml) after the plasmid pSHA2 carrying the OmpK36 porin
gene was cloned. Cefoxitin-resistant mutants were obtained by
plating LB4(pSHA2) on increasing concentrations of cefoxitin.
Mutants with increased resistance to cefoxitin (MIC, .48
mg/ml), determined according to the National Committee for
Clinical Laboratory Standards recommendations, were select-
ed and further characterized. The outer membrane proteins
(OMPs) from these mutants were isolated from bacterial en-
velopes as sodium lauryl sarcosinate-insoluble material (5) and
analyzed by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis. We found that expression of porin OmpK36 was
completely abolished in those mutants. In order to study pos-
sible mutations affecting the ompK36 gene, we isolated the
pSHA2 plasmid from the cefoxitin-resistant mutants. Plasmids
were analyzed by Southern blotting (4) with an ompK36 probe
obtained by PCR amplification of plasmid pSHA2 with primers
U228 (59-GGTAAAAAAAACCGGATGCG-39) and L1730
(59-CGTGCTTAGAACTGGTAAACC-39), which anneal to
sequences 427 bp upstream and 1,097 bp downstream of the
ompK36 start codon (accession no. Z33506), respectively.
These analyses revealed that different events occurred in the
ompK36 gene contained in pSHA2: point mutations or small
deletions, deletions of the entire gene, and insertions. These
mutant plasmids derived from pSHA2 were designated pSHA
followed by an arbitrary number (Table 1). As shown in Table
1, the most frequent types of changes detected in the mutant
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TABLE 1. Analysis of randomly selected mutant plasmids
conferring increased resistance to cefoxitin (MIC,
.48 mg/ml) derived from strain LB4(pSHA2)
Plasmid Type of mutation IS positiona
pSHA119 Point mutation or small deletion
pSHA124 Point mutation or small deletion
pSHA125 Point mutation or small deletion
pSHA128 Insertion of IS1 87
pSHA123 Insertion of IS903 8
pSHA103 Insertion of IS5 24
pSHA100 Insertion of IS26 14
pSHA146 Insertion of IS1 95
pSHA149 Insertion of IS5 7
pSHA151 Insertion of IS5 29
pSHA101 Insertion of IS26 77
pSHA154 Insertion of IS903 28
pSHA157 Deletion
pSHA104 Deletion






























plasmids were insertions. Among 14 randomly selected mu-
tants, 9 (64.3%) presented an insertion. Detailed characteriza-
tion of the nature and position of the inserted DNA was car-
ried out by sequencing the mutant plasmids. DNA sequencing
was performed with primers U681 (59-CGGTTACGGCCAG
TGGGAATA-39) and L1316 (59-GACGCAGACCGAAATC
GAACT-39), which represent DNA sequences 230 and 345 bp
downstream of the ompK36 start codon, and primers U228 and
L1730. We detected four different insertion sequences (ISs;
IS26, IS5, IS903, and IS1) located in different sites of the
ompK36 gene. Furthermore, with probes specific for the iden-
tified ISs (obtained by elution of an IS internal restriction
fragment from the corresponding mutant plasmid), we verified
by Southern blot analysis that the ISs were present in many
copies in the chromosome of the original strain LB4 (data not
shown).
Since resistance to cefoxitin in laboratory-derived mutants
was dependent on mutations of the OmpK36 porin gene, pre-
dominantly insertion of ISs, we investigated whether this type
of mechanism also occurred in vivo. For this purpose, we am-
plified the entire ompK36 gene from two pairs of strains iso-
lated from two patients before and after antimicrobial therapy:
strains LB1 and LB4 (9) and strains CMD1 and CMD2 (19).
LB4 and CMD2 are porin-deficient cefoxitin-resistant clinical
isolates derived from the porin-sufficient, cefoxitin-sensitive
strains LB1 and CMD1, respectively. Additionally, we charac-
terized the OmpK36 porin gene in 11 additional porin-defi-
cient K. pneumoniae clinical isolates: strains HUSR2/94, C1,
LB66, LB68, LB73, CSUB2, CSUB8R, CSUB9R, CSUB10R,
CSUB11, and CSUB12.
Analysis of the amplicons with the ompK36 gene probe de-
tected insertions, seen as increases in the size of ompK36, in
some of these clinical isolates (Fig. 1A). In addition, we ob-
served in strain HUSR2/94 a deletion on the OmpK36 porin
gene (Fig. 1A, lane 2). Further characterization of the above-
described insertions was obtained by sequencing the PCR am-
plicons. We identified the presence of IS102 in strain CMD2,
and we identified insertions with a high degree of sequence
identity to IS5 in the amplicons from strains LB73, CSUB2,
and CSUB11. These ISs were located in different positions
within the ompK36 coding region (Fig. 1B). These results dem-
onstrate that porin loss due to insertions of ISs within the porin
genes is a mechanism that operates in vivo in patients under-
going antibiotic treatment.
It has been suggested that a low level of random transposi-
tion might help cells to adapt to environmental changes and to
increase the survival rate (18), and it is also well known that ISs
can interrupt or alter gene expression. There are many exam-
ples in the literature where ISs have been involved in resistance
to certain antibiotics by creating novel promoters for antimi-
crobial resistance genes (8, 15). However, to our knowledge,
this is the first report where antimicrobial resistance is caused
by interruption of porin genes by ISs. Mechanisms of porin loss
and increased resistance to imipenem were also studied in
Pseudomonas aeruginosa by Yoneyama and Nakae by using an
in vitro approach (20): only deletions in the OprD2 porin gene
were observed. However, we have shown that, both in vitro and
in vivo, ISs cause porin deficiency in K. pneumoniae. ISs are
widespread in all bacterial species studied, and, although their
presence has not been correlated with antimicrobial resistance,
they have also been found in E. coli porins (13, 16). Thus,
interruption of porin genes by ISs is therefore not an exclusive
phenomenon of K. pneumoniae. Further studies will be re-
quired to determine the importance of this mechanism in other
bacterial species.
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